These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 30277862)
41. An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years. Campochiaro C; Allanore Y Arthritis Res Ther; 2021 Jun; 23(1):155. PubMed ID: 34074331 [TBL] [Abstract][Full Text] [Related]
43. Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement. De Luca G; Cavalli G; Campochiaro C; Bruni C; Tomelleri A; Dagna L; Matucci-Cerinic M Front Immunol; 2021; 12():653950. PubMed ID: 33833766 [TBL] [Abstract][Full Text] [Related]
44. Role of Alarmins in the Pathogenesis of Systemic Sclerosis. Giovannetti A; Straface E; Rosato E; Casciaro M; Pioggia G; Gangemi S Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679721 [TBL] [Abstract][Full Text] [Related]
45. Drugs in phase I and phase II clinical trials for systemic sclerosis. Chung MP; Chung L Expert Opin Investig Drugs; 2020 Apr; 29(4):349-362. PubMed ID: 32178544 [No Abstract] [Full Text] [Related]
46. Is biological therapy in systemic sclerosis the answer? Misra DP; Ahmed S; Agarwal V Rheumatol Int; 2020 May; 40(5):679-694. PubMed ID: 31960079 [TBL] [Abstract][Full Text] [Related]
47. The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis. Xu D; Mu R; Wei X Front Immunol; 2019; 10():2025. PubMed ID: 31572353 [TBL] [Abstract][Full Text] [Related]